We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Test Screens for Drug Resistant Bacteria

By LabMedica International staff writers
Posted on 08 Mar 2012
A laboratory-developed test combining enrichment broth and real-time polymerase chain reaction (rt-PCR) can screen for vancomycin-resistant enterococci (VRE).

The rt-PCR assay, which was developed specifically for the detection of VRE and known as Lab Assay, was evaluated and compared with a commercial VRE detection kit-based method.

Microbiologists at the Karolinska Institute (Stockholm, Sweden) investigated 1,765 fecal or rectal swabs sent to the laboratory for VRE screening in parallel by Lab Assay and the Roche LightCycler VRE kit. Two proven stains of Enterococcus faecium and 52 well-characterized clinical VRE isolates of different clones were tested in the study. Real-time PCR was performed for the detection of VanA and VanB genes.

The diagnostic values for Lab Assay were as follows: 100% sensitivity, 79.92% specificity, 1.94% positive predictive value and 100% negative predictive value, which were comparable to the results from the LightCycler kit-based assay. The detection limit of Lab Assay was 100 to 101 colony-forming units (CFU)/mL of inoculum in broth for both VanA-type and VanB-type VRE. The PCR method developed in the study was approved to be applicable on both the Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and the LightCycler 480 Real-Time PCR System (Roche Diagnostics GmbH; Mannheim, Germany).

The authors concluded that the flexibility in choosing PCR systems makes it possible that the PCR assay could be fully compatible with the DNA extraction’s platform, providing an integrated workflow. Furthermore, in the material cost around USD 10 per sample is saved when Lab Assay replaces the commercial kit-based method in their routine screening for VRE. Therefore, the laboratory-developed broth-PCR method is an efficient and economical assay for VRE screening. The study was published in March 2012 in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
Karolinska Institute
Applied Biosystems
Roche Diagnostics GmbH


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95

Latest Microbiology News

Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
08 Mar 2012  |   Microbiology

Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
08 Mar 2012  |   Microbiology

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
08 Mar 2012  |   Microbiology